Catalent (CTLT) Tops Q4 EPS by 8c, FY Revenue Guidance Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Catalent, Inc. Reports Fourth Quarter and Full Year 2017 Results
August 28, 2017 4:15 PM EDTQ4'17 revenue $616.9 million increased 16% as-reported, or 19% in constant currency from the prior-year period. FY'17 revenue $2,075.4 million increased 12% as-reported, or 15% in constant currency from the prior-year period. Entered into an exclusive long-term supply agreement to produce the next generation of Pfizer's leading OTC pain relief product with the launch of new Advil Liqui-Gels Minis. Increased spray drying and roller compaction capacity at our San Diego, California facility in response to market demand for solubility enhancement solutions.... More
